These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28199343)

  • 1. Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.
    Balandraud N; Texier G; Massy E; Muis-Pistor O; Martin M; Auger I; Guzian MC; Guis S; Pham T; Roudier J
    PLoS One; 2017; 12(2):e0171623. PubMed ID: 28199343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis.
    Balandraud N; Guis S; Meynard JB; Auger I; Roudier J; Roudier C
    Arthritis Rheum; 2007 Jun; 57(5):762-7. PubMed ID: 17530675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
    He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
    Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis.
    Couderc M; Payet S; Henquell C; Dubost JJ; Soubrier M
    Joint Bone Spine; 2010 Oct; 77(5):414-7. PubMed ID: 20542718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
    Mourgues C; Henquell C; Tatar Z; Pereira B; Nourisson C; Tournadre A; Soubrier M; Couderc M
    Joint Bone Spine; 2016 Jul; 83(4):412-5. PubMed ID: 26725744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab.
    Kawada J; Iwata N; Kitagawa Y; Kimura H; Ito Y
    Mod Rheumatol; 2012 Aug; 22(4):565-70. PubMed ID: 22057635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction.
    Balandraud N; Meynard JB; Auger I; Sovran H; Mugnier B; Reviron D; Roudier J; Roudier C
    Arthritis Rheum; 2003 May; 48(5):1223-8. PubMed ID: 12746895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
    Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis.
    Erre GL; Mameli G; Cossu D; Muzzeddu B; Piras C; Paccagnini D; Passiu G; Sechi LA
    Viral Immunol; 2015 Sep; 28(7):385-90. PubMed ID: 26083265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of Epstein-Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab.
    Fujieda M; Tsuruga K; Sato T; Kikuchi H; Tamaki W; Ishihara M; Yamamoto M; Oishi T; Tanaka H; Daibata M
    Mod Rheumatol; 2017 Jan; 27(1):66-71. PubMed ID: 27166661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
    Wadström H; Frisell T; Askling J;
    JAMA Intern Med; 2017 Nov; 177(11):1605-1612. PubMed ID: 28975211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
    Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
    J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies.
    Miceli-Richard C; Gestermann N; Amiel C; Sellam J; Ittah M; Pavy S; Urrutia A; Girauld I; Carcelain G; Venet A; Mariette X
    Arthritis Res Ther; 2009; 11(3):R77. PubMed ID: 19470150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
    Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
    Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis.
    Kuusela E; Kouri VP; Olkkonen J; Koivuniemi R; Äyräväinen L; Rajamäki K; Valleala H; Nordström D; Leirisalo-Repo M; Ainola M; Eklund KK
    Clin Exp Rheumatol; 2018; 36(5):778-784. PubMed ID: 29600942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.
    Jones G; Hall S; Bird P; Littlejohn G; Tymms K; Youssef P; Chung E; Barrett R; Button P
    Int J Rheum Dis; 2018 Aug; 21(8):1581-1590. PubMed ID: 29205926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
    J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study.
    Pascart T; Philippe P; Drumez E; Deprez X; Cortet B; Duhamel A; Houvenagel E; Flipo RM
    Int J Rheum Dis; 2016 Nov; 19(11):1093-1102. PubMed ID: 27018857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.